Meeting
2014 ASCO Annual Meeting
Clinical outcomes of patients with recurrent small cell lung cancer receiving third-line chemotherapy.
Authors
Koichi Saruwatari
National Cancer Center Hospital East, Kashiwa, Japan
Koichi Saruwatari , Shigeki Umemura , Shogo Nomura , Shingo Matsumoto , Kiyotaka Yoh , Seiji Niho , Koichi Goto , Hironobu Ohmatsu , Yuichiro Ohe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Small Cell Lung Cancer
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 7597)
DOI
10.1200/jco.2014.32.15_suppl.7597
Abstract #
7597
Poster Bd #
205
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
A new prognostic model in patients with recurrent or metastatic head and neck cancer treated with chemotherapy: An analysis of ECOG-ACRIN E1305.
First Author: Athanassios Argiris
Poster
2012 ASCO Annual Meeting
Time from prior chemotherapy (TFPC) as a prognostic factor in advanced urothelial carcinoma (UC) receiving second-line systemic therapy.
First Author: Gregory Russell Pond
Poster
2023 ASCO Annual Meeting
KRAS G12C-mutated pancreatic cancer: Clinical outcomes based on chemotherapeutic regimen.
First Author: Aaron Ciner
Poster
2021 ASCO Annual Meeting
Combination of quantitative features from H&E biopsies and CT scans predicts response to chemotherapy and overall survival in small cell lung cancer (SCLC).
First Author: Cristian Barrera